Immunoassay Market (By Technology: Enzyme Immunoassay (EIA) [Fluorescence Immunoassays (FIA), Chemiluminescence Immunoassays (CLIA)], Radioimmunoassay (RIA), Rapid test, Others; By Product: Analyzers/instruments [Closed ended systems, Open ended systems], Reagents & kits, Software & services; By Application: Endocrinology, Therapeutic drug monitoring, Autoimmune diseases, Infectious disease testing, Cardiology, Others; By End-Use: Hospitals, Pharmaceutical and biotech companies, Clinical laboratories, Academic research centers, Blood banks, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

the global Immunoassay market is expected to grow at significant CAGR around 4.9% throughout the forecast period and reach around US$ 26.1 billion by 2026.

The report provides analysis of global Immunoassay market for the period 2016-2026, wherein 2018 to 2026 is the forecast period and 2017 is considered as the base year.

Thanks to rising alcohol and drug testing, the global immunoassay market is growing at a fast pace over the next few years. Some of the key factors estimated for ensuring the development of the immunoassay market over the coming years are the technological developments in this field, together with the advent of new automated systems.

Market Dynamics

The major factors that are expected to contribute to a market development in the coming years are a significant increase for infectious and chronic diseases and the increase in the use of immunoassays in oncology. It is estimated that the increased geriatric population and technological progress in this area will speed up the overall market growth in the next several years. In the future, a further factor that will lead to potential opportunities for growth are the high development of biopharmaceutical and biotechnological industries.

On the flip side the unfavorable reimbursement environment is estimated to limit the development of the global immunoassay market in the coming years, and strict provisions and regulations relating to approvals of immunoassay consumables and tools. Furthermore, growing complexities are expected to reduce overall market developments in the next few years when performing diagnostic tests. The growing opportunities in the developing countries are nevertheless predicted to secure market growth in the next few years.
 
North America is anticipated to govern the Immunoassay Market

In recent years, the North American immunoassay market has held an enormous market share and is likely to continue to be the same for some years to come. In the coming years, the high number of research projects and the existing well-established healthcare infrastructures are projected to speed up the development of the North American immunoassay market. The growth of this region will be expected to be accelerated in the coming years as geriatric populations and the development of the biotechnology and pharmaceutical industries increase. In addition, the growth of Asia-Pacific in the future will be promising, thanks to the increasing number of In recent years, the North American immunoassay market has held an enormous market share and is likely to continue to be the same for some years to come.

Market Segmentation

Immunoassay Market by Technology

• Enzyme Immunoassay (EIA)
  
  • Fluorescence Immunoassays (FIA)
  • Chemiluminescence Immunoassays (CLIA)
• Radioimmunoassay (RIA)
• Rapid test
• Others

Immunoassay Market by Product

• Analyzers/instruments
  
  • Closed ended systems
  • Open ended systems
• Reagents & kits
• Software & services

Immunoassay Market by Application

• Endocrinology
• Therapeutic drug monitoring
• Autoimmune diseases
• Infectious disease testing
• Cardiology
• Others

Immunoassay Market by End-Use

• Hospitals
• Pharmaceutical and biotech companies
• Clinical laboratories
• Academic research centers
• Blood banks
• Others

Global Immunoassay Market, by Geography

• North America
• U.S.
• Canada
• Mexico

• Europe
• UK
• Germany
• France
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• Australia
• Rest of Asia-Pacific
• Latin America
• Brazil
• Chile
• Rest of Latin America

• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• Rest of MEA

The market research study on “Immunoassay Market (By Technology: Enzyme Immunoassay (EIA) [Fluorescence Immunoassays (FIA), Chemiluminescence Immunoassays (CLIA)], Radioimmunoassay (RIA), Rapid test, Others; By Product: Analyzers/instruments [Closed ended systems, Open ended systems], Reagents & kits, Software & services; By Application: Endocrinology, Therapeutic drug monitoring, Autoimmune diseases, Infectious disease testing, Cardiology, Others; By End-Use: Hospitals, Pharmaceutical and biotech companies, Clinical laboratories, Academic research centers, Blood banks, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers detailed insights on global Immunoassay market segments with market dynamics and their impact.

Market Participants

The key players of the market are Dickinson & Company; Becton, Thermo Fisher Scientific, Inc.; BioMérieux; Siemens Healthineers; Abbott laboratories; Roche Diagnostics; Sysmex Corporation; Danaher Corporation; Ortho Clinical Diagnostics; and Quidel Corporation.